WHO-GMP ACCREDITATION FOR PARABOLIC CEPHALOSPORIN FACILITY
The Company’s dedicated Cephalosporin API manufacturing Site at Derabassi has been accredited with the WHO-GMP certificate by the Central Drugs Standards Control Organization, DGHS, Ministry of Health & Family Welfare.
The Derabassi Campus, housing six manufacturing Plants, two Solvant Recovery Plants, a dedicated Quality Control and Quality Assurance unit, Research & Development wing and Administration blocks was inspected by the Central agency in September and found to be compliant with World health Organization’s Good manufacturing Standards.
This WHO-GMP certificate will give further impetus to Company’s API exports to countries where submission of a “Certificate of Pharmaceutical Product” i.e. COPP issued as per WHO-GMP is a preliminary requirement for marketing in that country.